What is BeyondSpring Inc?
, a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 13.66M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.